Antiandrogenic effect of spironolactone in rats.
D000726:Androgen Antagonists; D000818:Animals; D001284:Atrophy / Q000473:pathology; D001835:Body Weight / Q000187:drug effects; D003593:Cytoplasm; D004847:Epithelial Cells; D007279:Injections, Subcutaneous; D008297:Male; D009929:Organ Size; D011467:Prostate / Q000187:drug effects* / Q000473:pathology; D051381:Rats; D012669:Seminal Vesicles / Q000187:drug effects* / Q000473:pathology; D013148:Spironolactone / Q000008:administration & dosage / Q000494:pharmacology*; D001743:Urinary Bladder / Q000187:drug effects / Q000473:pathology; D014649:Vas Deferens / Q000187:drug effects / Q000473:pathology
D000726:Androgen Antagonists; D013148:Spironolactone